RDY Adds to Generic Portfolio

News | 21 May 2012

• Print This

Dr. Reddy's Laboratories (RDY - Snapshot Report) has been busy launching generics and the recent US launch of a generic version of Novatis AG's (NVS - Snapshot Report) over-the-counter (OTC) drug, Prevacid, was the second one in less than a week.

Click on the link to read the full article at Zacks.com
(This link will open in a new window)